
Investors in PCRX Have a Chance to Take the Lead in Pacira Biosciences Securities Fraud Lawsuit
Rosen Law Firm Reminds Investors of Lead Plaintiff Deadline in Pacira BioSciences, Inc. Securities Class Action NEW YORK, Feb. 17, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Pacira BioSciences, Inc. (NASDAQ: PCRX) between August 2, 2023 and August 8, 2024, both dates inclusive (the “Class…